Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treprostinil Sodium in Severe Non-operable CTEPH
NCT01416636Phase 3Completed
- Sponsor
- SciPharm
- Start
- Mar 2009
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of treprostinil in chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by SciPharm. Started Mar 2009; status: completed.
02
Drugs
treprostinil
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on NCT01416636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416636.